Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma

Journal of Clinical Investigation

Volumn 103, Issue 7, 1999, Pages 989-997

  Stafforini, Diana M ^a,d   Numao, Toshio ^b   Tsodikov, Alexander ^a   Vaitkus, Darius ^a   Fukuda, Takeshi ^c   Watanabe, Naoto ^c   Fueki, Naoto ^c   McIntyre, Thomas M ^d   Zimmerman, Guy A ^d   Makino, Sohei ^b   Prescott, Stephen M ^a  

^a UNIVERSITY OF UTAH   (United States)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c Department of Medicine   (Japan)

^d UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; THROMBOCYTE ACTIVATING FACTOR;

ADULT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; COMPLEX FORMATION; DESENSITIZATION; ENZYME DEFICIENCY; FEMALE; GENE LOCUS; HUMAN; INFLAMMATORY CELL; LUNG ALVEOLUS MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MAST CELL; MEDIATOR RELEASE; MISSENSE MUTATION; PRIORITY JOURNAL;

EID: 0032901161     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI5574     Document Type: Article

References (56)

1. Lemanske, R.F., Jr. and Busse, W.W. 1997. Asthma. JAMA. 278:1855-1873.
2. Drazen, J.M. 1998. New directions in asthma drug therapy. Hosp. Pract. 33:25-26.
3. Davies, R.J., et al. 1997. New insights into the understanding of asthma. Chest. 111:2S-10S.
4. Rachelefsky, G. 1997. Childhood asthma and allergic rhinitis: the role of leukotrienes. J. Pediatr. 131:348-355.
5. Page, C.P. 1988. The role of platelet-activating factor in asthma. J. Allergy Clin. Immunol. 81:44-152.
6. Nadel, J.A. 1996. Genetics reveals importance of platelet activating factor in asthma and possibly other inflammatory states. J. Clin. Invest. 97:2689-2690.
7. Imaizumi, T.A., et al. 1995. Platelet-activating factor: a mediator for clinicians. J. Intern. Med. 238:5-20.
8. Kurosawa, M., Yamashita, T., and Kurimoto, F. 1994. Increased levels of blood platelet-activating factor in bronchial asthmatic patients with active symptoms. Allergy. 49:60-63.
9. Nakamura, T., et al. 1987. Platelet-activating factor in late asthmatic response. Int. Arch. Allergy Appl. Immunol. 82:57-61.
10. Hsieh, K.H., and Ng, C.K. 1993. Increased plasma platelet-activating factor in children with acute asthmatic attacks and decreased in vivo and in vitro production of platelet-activating factor after immunotherapy. J. Allergy Clin. Immunol. 91:650-657.
11. Beer, J.H., Wuthrich, B., and von Felten, A. 1995. Allergen exposure in acute asthma causes the release of platelet-activating factor (PAF) as demonstrated by the desensitization of platelets to PAF. Int. Arch. Allersy Immunol. 106:291-296.
12. Nagase, T., et al. 1997. Airway responsiveness in transgenic mice overexpressing platelet- activating factor receptor. Roles of thromboxanes and leukotrienes. Am. J. Respir. Crit. Care Med. 156:1621-1627.
13. Shirasaki, H., et al. 1994. Expression of platelet-activating factor receptor mRNA in human and guinea pig lung. Am. J. Respir. Cell Mol. Biol. 10:533-537.
14. Kuitert, L., and Barnes, N.C. 1995. PAF and asthma-time for an appraisal? Clin. Exp. Allergy. 25:1159-1162.
15. Zimmerman, G.A., McIntyre, T.M., Prescott, S.M., and Stafforini, D.M. 1996. Platelet-activating factor: antagonists, terminators, molecular mimics, and microbial opportunism. J. Intern. Med. 239:463-466.
16. Evans, D.J., Barnes, P.J., Cluzel, M., and O'Connor, B.J. 1997. Effects of a potent platelet-activating factor antagonist, SR27417A, on allergen-induced asthmatic responses. Am. J. Respir. Crit. Care Med. 156:11-16.
17. Tamura, G., et al. 1996. Effect of a potent platelet-activating factor antagonist, WEB-2086, on asthma. A multicenter, double-blind placebo-controlled study in Japan. Adv. Exp. Med. Biol. 416:371-380.
18. Hozawa, S., Haruta, Y., Ishioka, S., and Yamakido, M. 1995. Effects of a PAF antagonist, Y-24180, on bronchial hyperresponsiveness in patients with asthma. Am. J. Respir. Crit. Care Med. 152:1198-1202.
19. Arima, M., Yukawa, T., and Makino, S. 1995. Effect of YM264 on the airway hyperresponsiveness and the late asthmatic response in a guinea pig model of asthma. Chest. 108:529-534.
20. Kagoshima, M., et al. 1997. Effects of Y-24180, a long-acting and potent antagonist to platelet-activating factor, on immediate asthmatic response in guinea pigs. Pharmacology. 54:1-7.
21. Bazan, N.G. 1995. Inflammation. A signal terminator. Nature. 374:501-502.
22. Stafforini, D.M., McIntyre, T.M., Zimmerman, G.A., and Prescott, S.M. 1997. Platelet-activating factor acetylhydrolases. J. Biol. Chem. 272:17895-17898.
23. Miwa, M., et al. 1988. Characterization of serum platelet-activating factor(PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J. Clin. Invest. 82:1983-1991.
24. Stafforini, D.M., et al. 1996. Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase. J. Clin. Invest. 97:2784-2791.
25. Grossman, J. 1997. One airway, one disease. Chest. 111:115-165.
26. 1997. The genetics of asthma. Am. J. Respir. Crit. Care Med. 156:569-S162.
27. In, K.H., et al. 1997. Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J. Clin. Invest. 99:1130-1137.
28. National Asthma Education and Prevention Program. 1997. Expert panel report. II. Guidelines for the diagnosis and management of asthma. NIH publication 97-4051A. National Institutes of Health. Bethesda, MD.
29. Stafforini, D.M., McIntyre, T.M., and Prescott, S.M. 1990. Platelet-activating factor acetylhydrolase from human plasma. Methods Enzymol. 187:344-357.
30. Tjoelker, L.W., et al. 1995. Plasma platelet-activating factor acetylhydrolase is a secreted phospholipase A2 with a catalytic triad. J. Biol. Chem. 270:25481-25487.
31. McCullaugh, P. Regression models of ordinal data. 1980. J. Royal Stat. Soc. 42:109-142.
32. Tsodikov, A., Hasenclever, D., and Loeffler, M. 1998. Regression with bounded outcome score: evaluation of power by bootsstrap and simulation in a chronic myelogenous leukaemia clinical trial. Stat. Med. 17:1909-1922.
33. Tsukioka, K., Matsuzaki, M., Nakamata, M., and Kayahara, H. 1993. Increased plasma levels of platelet-activating factor (PAF) and low serum PAF acetylhydrolase (PAFAH) activity in adult patients with bronchial asthma. Arerugi. 42:167-171.
34. Tsukioka, K., Matsuzaki, M., Nakamata, M., Kayahara, H., and Nakagawa, T. 1996. Increased plasma level of platelet-activating factor (PAF) and decreased serum PAF acetylhydrolase (PAFAH) activity in adults with bronchial asthma. J. Investig. Allergol. Clin. Immunol. 6:22-29.
35. Miyaura, S., Eguchi, H., and Johnston, J.M. 1992. Effect of a cigarette smoke extract on the metabolism of the proinflammatory autacoid, platelet-activating factor. Circ. Res. 70:341-347.
36. Imaizumi, T., et al. 1990. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from healthy habitual cigarette smokers. Heart Vessels. 5:81-86.
37. Yasuda, K., and Johnston, J.M. 1992. The hormonal regulation of platelet-activating factor-acetylhydrolase in the rat. Endocrinology. 130:708-716.
38. Miyaura, S., Maki, N., Byrd, W., and Johnston, J.M. 1991. The hormonal regulation of platelet-activating factor acetylhydrolase activity in plasma. Lipids. 26:1015-1020.
39. Maki, N., Hoffman, D.R., and Johnston, J.M. 1988. Platelet-activating factor acetylhydrolase activity in maternal, fetal, and newborn rabbit plasma during pregnancy and lactation. Proc. Natl. Acad. Sci. USA. 85:728-732.
40. Yasuda, K., Takashima, M., and Sawaragi, I. 1995. Influence of a cigarette smoke extract on the hormonal regulation of platelet-activating factor acetylhydrolase in rats. Biol. Reprod. 53:244-252.
41. Tjoelker, L.W., et al. 1995. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature. 374:549-553.
42. Yamada, Y., and Yokota, M. 1997. Loss of activity of plasma platelet-activating factor acetylhydrolase due to a novel Gln281→Arg mutation. Biochem. Biophys. Res. Commun. 236:772-775.
43. Bell, R., et al. 1997. Systematic screening of the LDL-PLA2 gene for polymorphic variants and case-control analysts in schizophrenia. Biochem. Biophys. Res. Commun. 241:630-635.
44. Tetta, C., et al. 1990. Release of platelet-activating factor in systemic lupus erythematosus. Int. Arch. Allergy Appl. Immunol. 91:244-256.
45. Graham, R.M., et al. 1994. Platelet and plasma platelet-activating factor in sepsis and myocardial infarction. J. Lipid Mediat. Cell Signal. 9:167-182.
46. Cookson, W.O., and Moffatt, M.F. 1997. Asthma: an epidemic in the absence of infection? Science. 275:41-42.
47. Nakamura, Y., and Labarthe, D.R. 1994. Secular trends in mortality from asthma in Japan, 1979-1988: comparison with the United States. Int. J. Epidemiol. 23:143-147.
48. National Heart, Lung and Blood Institution and the World Health Organization. 1995. Global initiative for asthema. NIH publication 95-3659. National Institutes of Health. Bethesda, MD.
49. Zimmerman, G.A., Prescott, S.M., and McIntyre, T.M. 1995. Oxidatively fragmented phospholipids as inflammatory mediators: the dark side of polyunsaturated lipids. J. Nutr. 125:1661S-1665S.
50. Lehr, H.A., et al. 1997. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking. J. Clin. Invest. 98:2358-2364.
51. Antczak, A., et al. 1997. Increased hydrogen peroxide and thiobarbicuric acid-reactive products in expired breath condensate of asthmatic patients. Eur. Respir. J. 10:1235-1241.
52. Jöbsis, Q., Raatgeep, H.C., Hermans, P.W., and de Jongste, J.C. 1997. Hydrogen peroxide in exhaled air is increased in stable asthmatic children. Eur. Respir. J. 10:519-521.
53. Cluzel, M., et al. 1987. Enhanced alveolar cell luminol-dependent chemiluminescence in asthma. J. Allergy Clin. Immunol. 80:195-201.
54. Ambrosio, G., et al. 1994. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor. J. Clin. Invest. 93:2408-2416.
55. Stremler, K.E., et al. 1989. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma. J. Biol. Chem. 264:5331-5334.
56. Stremler, K.E., Stafforini, D.M., Prescott, S.M., and McIntyre, T.M. 1991. Human plasma platelet-activating factor acetylhydrolase, Oxidatively fragmented phospholipids as substrates. J. Biol. Chem. 266:11095-11103.